期刊文献+

唐氏综合征无创产前筛查策略的经济学系统评价 被引量:17

Systematic review of the economic evaluations of Non-Invasive Prenatal Testing(NIPT)strategies for Down syndrome
在线阅读 下载PDF
导出
摘要 目的:系统评价唐氏综合征无创产前检测技术(NIPT)的经济性。方法:检索与唐氏综合征NIPT经济学评价相关的文献,对纳入文章进行质量评价,运用描述性方法系统评价筛查策略的经济性。结果:根据纳入和排除的标准,两名评价人员独立评价文献质量后,共纳入15篇文献,文献质量得分在18分以上的占46.7%。其中有10项研究涉及将NIPT作为二次深度筛查提供给孕妇,12项研究涉及将NIPT提供给所有孕妇,3项研究涉及将NIPT提供给>35岁孕妇的筛查策略,1项研究涉及将NIPT作为产前诊断手段。目前将NIPT作为二次深度筛查提供给孕妇被认为是成本效果更好的策略。结论:NIPT是十分有应用前景的一种新技术,目前不推荐所有孕妇使用NIPT,如果其与当前的孕母血清学筛查更好地结合使用,作为条件筛查策略则经济性更好。随着未来价格的降低,它的经济性将会更为显著。 Objective: To systematically review the economic evaluations of non-invasive prenatal testing( NIPT ) for Down syndrome. Methods: Literature review on economic evaluations of NIPT for Down syndrome were conducted, the quality of the literatures was assessed, and descriptive analysis was conducted to systematically evaluate the economic implications of prenatal screening strategy for Down syndrome. Results: Fifteen studies were included in the review based on the inclusion and exclusion criteria adopted. Two researchers independently evaluated the quality of the studies and 46.7% of the chosen studies were scored 18 points or higher. In 10 studies, NIPT was used as a contingent screening strategy for high-risk pregnancies following conventional screening. In 12 studies, NIPT was used for universal screening. Three studies used it as a hybrid strategy, in which NIPT was offered to all pregnant women aged over 35 years old. One study used NIPT was a prenatal screening strategy. Generally speaking, the contingent strategy was considered more costeffective. Conclusion: NIPT is a promising new technology for testing pregnant women for Down syndrome, contingent screening strategy could be cost-effective if properly designed and well integrated with existing screening strategies. Costs of using NIPT will likely to decrease as it becomes more widelv used and less costly in the future.
作者 许艳 李娜 明坚 庞伟明 陈英耀 XU Yan LI Na MING Jian PONG Raymood W CHEN Ying-yao(School of Public Health, Fudan University/Key Laboratory of Health Technology Assessment of National Health and Family Planning Commission/ Collaborative Innovation Center of Social Risks Governance in Health, Shanghai 200032, China Centre for Rural and Northern Health Research, Laurentian University, P3E 2C6 Ontario Canada ).)
出处 《中国卫生资源》 北大核心 2017年第2期123-127,141,共6页 Chinese Health Resources
基金 2015年国家卫生计生委卫生技术评估项目资助 美国中华医学基金会卫生技术评估合作项目资助(13-153)
关键词 唐氏综合征 无创产前检测技术 经济性 系统评价 Down syndrome non-invasive prenatal testing economic assessment systematic evaluation
  • 相关文献

参考文献3

二级参考文献38

  • 1郭?,高锦声.孕妇血清AFP、HCG、UE_3三联标记筛查Down综合征的研究进展[J].中国计划生育学杂志,1996,4(4):250-253. 被引量:6
  • 2陈英耀,王斌,李军,石琦,张洁,钱序,朱怡蓓,陈洁.产前诊断预防唐氏综合征策略的经济学评价[J].中国卫生经济,2006,25(5):49-52. 被引量:11
  • 3World Atlas of Birth Defects. 2nd Edition. Geneva: WHO. 2003. 151-153.
  • 4Richard K. E., Thomas L.C. Life Expectancy of Persons with Down syndrome. American Journal on Mental Retardation. 1991, 95(6):603-612.
  • 5United Nations Development Program. Human development report.2OO3.
  • 6Waitzman NJ, Romano PS, Schemer RM. Economic Costs of Birth Defects and Cerebral Palsy-United States 1992. MMWR, 1995, 44(37) : 694-699.
  • 7杨永青 肖祥熊.放射免疫分析的正常和异常值[M].武汉:同济大学出版社,1998,1..
  • 8高锦声.人类染色体方法学手册.第2版,南京:江苏省科学技术情报所出版,1982:1
  • 9Alfirevic Z, Gosden CM, Neilson JP. Chorion villus sampling versus amniocentesis for prenatal diagnosis [ J ]. Cochrane Database Syst Rev, 2000 : CD000055.
  • 10Nicolaides KH. The 11-13 +6 weeks scan [ M ]. London: Fetal Medicine Foundation, 2004 : 16.

共引文献122

同被引文献123

引证文献17

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部